-
-
#ECTRIMS2019 — Glia Score May Differentiate Progressive MS from RRMS, Study Suggests
Patients with progressive multiple sclerosis (MS) have higher levels of protein markers of activated glial cells than those with relapsing-remitting MS (RRMS) or patients ... Read more -
MS News that Caught My Eye Last Week: Stem Cell Transplants, Remyelination Agent, Tecfidera Study, Plasma Exchange and Tysabri-linked PML
It’s been a big week for interesting stories, as the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) ... Read more -
#ECTRIMS2019 – Nerve Cell Damage May Be Evident Years Before Symptoms Are
Damage to nerve cells appears to occur years before people with multiple sclerosis (MS) begin to show symptoms and is evident in a likely ... Read more -
#ECTRIMS2019 – Newer DMTs More Effective Than Older Injectables in Pediatric MS, Study Says
Using newer disease-modifying therapies (DMTs) as an initial treatment for children and adolescents with multiple sclerosis (MS) or clinically isolated syndrome (CIS) is associated ... Read more
Neurological reserve: How the brain can adapt to MS damage Sponsored Post
When your brain is injured or damaged, it has a natural ability to adapt and continue functioning. If you’re living with multiple sclerosis (MS), this ability, called “neurological reserve,” ... Read more
